
Sanofi Enters Research Pact with Hong Kong’s Insilico
French pharma Sanofi has entered a multi-year, multi-target research collaboration worth up to $1.2 billion with Hong Kong biotech Insilico Medicine.

French pharma Sanofi has entered a multi-year, multi-target research collaboration worth up to $1.2 billion with Hong Kong biotech Insilico Medicine.

Michael Bloomberg, the founder of US-based financial, software, data and media group Bloomberg LP and a United Nations special envoy on climate ambition and solutions, has launched a campaign to stop the expansion of petrochemicals and plastics production in the US.

Air Liquide, Chevron, PetroChina and Keppel Infrastructure are planning to form a consortium that will explore the development of large-scale carbon capture, utilization and sequestration (CCUS) solutions and integrated infrastructure in Singapore.



















Ten years ago, in March 2007, oxo chemicals producer Oxea was established as a buyout led by private-equity firm Advent International of oxo derivatives and oxo intermediates businesses from Celanese and European Oxo.












